MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

The anti-obesity drug boom may be cooling, as overall prescribing of GLP-1 medicines remained relatively flat for the three ...

The findings suggest weight loss drugs independently affect heart health risks, researchers said. View on euronews ...

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much ...

Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...

Prescribing rates remained stable from June to September, according to an analysis of EHR data from researchers at Truveta — a platform that includes ...

WASHINGTON—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed ...

"Given the escalating obesity rates, especially severe obesity among women, and the growing popularity of anti-obesity medications, exploring the association between anti-obesity medication and ...